Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'depressive' OR with Authors including 'depressive' OR with Abstract including 'depressive' OR with Keywords including 'depressive'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Sloane B, Doust JWL Psychophysiological investigations in experimental psychoses: results ... J. Ment. Sci. 1954
Abramson HA, Jarvik ME, K... Lysergic acid diethylamide (LSD-25): I. Physiological and perceptual r... J. Psychol. 1955
de Salva S, Evans RA Reversal of the effects of central nervous system depressants on EST b... J. Pharmacol. & Expe... 1958
Eisner BG, Cohen S Psychotherapy with lysergic acid diethylamide J Nerv Ment Dis 1958
Bulle PH Neurohumors in psychoses Chemical concepts of... 1958
Cohen S, Eisner BG Use of Lysergic acid diethylamide in a psychotherapeutic setting Arch.Neurol.Psychiat... 1959
Weintraub W, Silverstein ... The effect of LSD on the associative processes J.Nerv.Ment.Dis. 1959
Elmadjian F Excretion and metabolism of epinephrine and norepinephrine in man. Molecules and Mental... 1959
Ziolko HU Psychotrope Drogenwirkung und psychische Ausgangslage (Neurose) Neuro-Psychopharmaco... 1959
Quétin AM La Psilocybine en psychiatrie clinique et expérimentale Doctoral Thesis 1960
Wijsenbeek H, Landau R A review on the use of lysergic acid diethylamide (LSD-25) in psychiat... Harefuah 1960
Jovanovic D, Kandic B, Kr... Neka nasa iskustva u lecenju dusevnih bolesnika dietilamidom lizergicn... Vojno-sanit.Pregl. 1960
Jovanovic D, Kandic B, Kr... O nekim aspektima primene LSD-25 u nasoj Klinickoj psihijatrijsdkoj pr... Vojnosanit. Pregl. 1960
Shirahashi K Electroencephalographic study of mental disturbances experimentally-in... Folia Psychiat. Neu... 1960
Ling TM, Buckman J The use of lysergic acid in individual psychotherapy Proc. roy. Soc. Med. 1960
Rosen I Hallucinogenic drugs. Specific problems. Lancet 1961
DJ Douche Les effets de la psilocybine dans un cas d'hysterie Semaine d. hop. 1961
Sercl M, Lovarik J, Jaros... Klinische Erfahrungen mit Psilocybin (CY 39 Sandoz) Psychiatria et Neuro... 1961
Cosi V, Martinelli C Esperienze cliniche con la psilocibina nelle sindromi depressive Rass Studi Psichiat 1965
Cohen S A classification of LSD complications Psychosomatics 1966
Pöldinger W Zur Pharmakotherapie depressiver und ängstlicher Verstimmungszustände Osterreichische Apot... 1973
Munch JC Phencyclidine: pharmacology and toxicology Bulletin on Narcotic... 1974
Everitt BJ, Fuxe K, Hokfe... Serotonin, Catecholamines and Sexual Receptivity of Female Rats, Pharm... J Pharmacol 1975
Loo H, Caroli F La Conduite Toxicomaniaque dens ses Rapports a la Conduite Suicidaire Ann.Med.-Psychol 1975
Bowers MB Psychoses Precipitated by Psychotomimetic Drugs: A Follow-up Study Arch.Gen.Psychiat. 1977
Natale M, Dahlberg CC, Ja... The Effects Of LSD-25 And Dextroamphetamine On The Use Of Defensive La... J. clin. Psychol. 1979
Editorial Tod-geweihte: LSD hilft sterben Selecta 1980
Francès H, Lecrubier Y, P... Evidence for the role of noradrenaline in some effects of quipazine Psychopharmacology (... 1980
Carter SM, Reveley MA, Sa... Decreased urinary output of conjugated tyramine is associated with lif... Psychiatry Res 1980
Weaver KEC Letters to the Editor: LSD and Schizophrenia Arch. Gen. Psychiatr... 1984
Warnecke G [Psychosomatic dysfunctions in the female climactericClinical effectiv... Fortschr Med 1991
Gamma A, Frei E, Lehmann ... Mood state and brain electric activity in ecstasy users Neuroreport 1999
Berman RM, Cappiello A, A... Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000
Gamma A, Buck A, Berthold... No difference in brain activation during cognitive performance between... J Clin Psychopharmac... 2001
MacInnes, N, Handley, SL ... Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... J Psychopharmacology 2001
McGregor IS, Gurtman CG, ... Increased anxiety and "depressive" symptoms months after MDMA ("ecstas... Psychopharmacology (... 2003
De Win MM, Reneman L, Rei... Mood disorders and serotonin transporter density in ecstasy users-the ... Psychopharmacology (... 2004
London ED, Simon SL, Berm... Mood disturbances and regional cerebral metabolic abnormalities in rec... Arch Gen Psychiatry 2004
Khorana N, Pullagurla MR,... Pharmacological and neurochemical evidence for antidepressant-likeeffe... Pharmacology, Bioche... 2004
Sumnall HR, Cole JC Self-reported depressive symptomatology in community samples of polysu... J Psychopharmacol 2005
Ranjan S, Chandra PS Modafinil-induced irritability and aggression?: a report of 2 bipolar ... J Clin Psychopharmac... 2005
Hayase T, Yamamoto Y, Yam... Behavioral effects of ketamine and toxic interactions with psychostimu... BMC Neurosci 2006
Furey ML, Drevets WC Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... Arch Gen Psychiatry 2006
Braida D, Limonta V, Pego... Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... Psychopharmacology (... 2007
Linde K, Berner MM, Krist... St John's wort for major depression Cochrane Database of... 2008
Moussaieff A, Rimmerman N... Incensole acetate, an incense component, elicits psychoactivity by act... FASEB J 2008
Chartoff EH, Potter D, Da... Exposure to the Selective kappa-Opioid Receptor Agonist Salvinorin A M... Neuropsychopharmacol... 2008
Rogers G, Elston J, Garsi... The harmful health effects of recreational ecstasy: a systematic revie... Health Technol Asses... 2009
Kuchkarov UI, Ashurov ZSh... [Efficiency of noophen in heroin addiction] Lik Sprava 2009
Akinboro A, Mohamed KB, A... Antioxidants in aqueous extract of Myristica fragrans (Houtt.) suppres... J Zhejiang Univ-Sci ... 2011
Bell HJ, Azubike E, Haouz... The other respiratory effect of opioids: suppression of spontaneous au... J Appl Physiol (1985... 2011
Degenhardt L, Coffey C, R... The persistence of the association between adolescent cannabis use and... Addiction 2012
Niciu MJ, Grunschel BD, C... Two cases of delayed-onset suicidal ideation, dysphoria and anxiety af... J Psychopharmacol 2013
Zanos P, Georgiou P, Wrig... The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Str... Neuropsychopharmacol... 2013
Ellis JS, Zarate CA, Luck... Antidepressant treatment history as a predictor of response to scopola... Journal of Affective... 2014
Lally N, Nugent AC, Lucke... Anti-anhedonic effect of ketamine and its neural correlates in treatme... Transl Psychiatry 2014
Nagele P, Duma A, Kopec M... Nitrous Oxide for Treatment-Resistant Major Depression: a Proof-of-Con... Biological Psychiatr... 2014
Zorumski CF, Nagele P, Me... Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... Front Psychiatry 2015
Henderson TA Practical application of the neuroregenerative properties of ketamine:... Neural Regen Res 2016
Gao M, Rejaei D, Liu H Ketamine use in current clinical practice Acta Pharmacol Sin 2016
Grunebaum MF, Galfalvy HC... Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression:... Am J Psychiatry 2017
Morley S, Slaughter J, Sm... Death from Ingestion of E-Liquid Journal of Emergency... 2017
Geiger HA, Wurst MG, Dani... DARK Classics in Chemical Neuroscience: Psilocybin ACS Chem Neurosci 2018
Zhang K, Hashimoto K Lack of Opioid System in the Antidepressant Actions of Ketamine Biol Psychiatry 2019
Cozzi NV, Daley PF Synthesis and characterization of high-purity N,N-dimethyltryptamine h... Drug Test Anal 2020
Nicholas B.GiancolaBAClay... A “trip” to the ICU: intravenous injection of psilocybin Journal of the Acade... 2021